Advisor Partners’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$639K Buy
4,808
+270
+6% +$36.8K 0.05% 406
2022
Q1
$621K Sell
4,538
-5
-0.1% -$697 0.04% 447
2021
Q4
$786K Buy
4,543
+246
+6% +$37.4K 0.05% 377
2021
Q3
$624K Sell
4,297
-132
-3% -$19.3K 0.04% 420
2021
Q2
$584K Buy
4,429
+26
+0.6% +$3.4K 0.04% 456
2021
Q1
$565K Sell
4,403
-170
-4% -$20.9K 0.04% 449
2020
Q4
$545K Buy
4,573
+273
+6% +$33.3K 0.04% 432
2020
Q3
$492K Sell
4,300
-348
-7% -$41.1K 0.04% 395
2020
Q2
$530K Buy
4,648
+332
+8% +$35.2K 0.05% 354
2020
Q1
$346K Sell
4,316
-5,580
-56% -$578K 0.04% 398
2019
Q4
$1.06M Buy
9,896
+6,469
+189% +$675K 0.11% 183
2019
Q3
$367K Buy
3,427
+269
+9% +$27.6K 0.04% 403
2019
Q2
$321K Buy
3,158
+445
+16% +$42.8K 0.04% 442
2019
Q1
$244K Buy
2,713
+56
+2% +$4.85K 0.03% 517
2018
Q4
$221K Sell
2,657
-832
-24% -$78K 0.04% 505
2018
Q3
$377K Buy
3,489
+63
+2% +$6.91K 0.05% 380
2018
Q2
$377K Buy
3,426
+288
+9% +$30K 0.06% 355
2018
Q1
$315K Buy
3,138
+23
+0.7% +$2.36K 0.06% 373
2017
Q4
$321K Buy
3,115
+691
+29% +$65.5K 0.06% 379
2017
Q3
$227K Sell
2,424
-177
-7% -$18.8K 0.04% 425
2017
Q2
$289K Buy
2,601
+72
+3% +$7.61K 0.07% 346
2017
Q1
$248K Buy
2,529
+276
+12% +$26.3K 0.07% 362
2016
Q4
$207K Buy
+2,253
New +$194K 0.06% 386

Other funds holding DGX

Advisor Partners's DGX Position: Q2 2022 in Review

Advisor Partners increased its Quest Diagnostics (DGX) stake by 5.9% in Q2 2022, buying an estimated $36.8K and bringing the position to 4,808 shares worth $639K. The position accounts for 0.05% of the portfolio, ranked #406.

Advisor Partners first reported a position in DGX in Q4 2016 and has held it in 23 quarters since. The position peaked at $1.06M in Q4 2019. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Advisor Partners held 4,808 shares of Quest Diagnostics worth $639K as of Q2 2022.
  • Advisor Partners bought 270 Quest Diagnostics shares in Q2 2022, an estimated $36.8K.
  • Quest Diagnostics made up 0.05% of Advisor Partners's portfolio in Q2 2022, its #406 holding.
  • Advisor Partners first reported a position in Quest Diagnostics in Q4 2016 and has held it in 23 quarters since.
  • Advisor Partners's Quest Diagnostics position peaked at $1.06M in Q4 2019.
  • 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.